Header cover image

Israeli (TA) Pharma Industry Analysis

UpdatedJun 30, 2022
DataAggregated Company Financials
Companies8
  • 7D3.3%
  • 3M-17.2%
  • 1Y-35.0%
  • YTD-13.7%

In the last week, the Pharma industry is up 3.3%, with Rekah Pharmaceutical Industry leading the way, up 8.4%. Meanwhile, Nextgen Biomed actually underperformed within the industry, shrinking 5.6% in the last week. However, the industry is down 35% over the past year. Looking forward, earnings are forecast to grow by 91% annually.

Industry Valuation and Performance

Has the Israeli Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 01 Jul 2022₪1.7b₪731.4m-₪119,323,194.0045x
Sun, 29 May 2022₪1.8b₪731.4m-₪117,214,504.0043.7x
Tue, 26 Apr 2022₪1.8b₪669.4m-₪122,093,632.0036.9x
Thu, 24 Mar 2022₪1.9b₪598.9m-₪111,250,724.0048x
Sat, 19 Feb 2022₪1.9b₪598.9m-₪110,989,917.0047.5x
Mon, 17 Jan 2022₪2.0b₪598.9m-₪95,834,215.0051x
Wed, 15 Dec 2021₪2.0b₪559.8m-₪169,685,797.0049x
Fri, 12 Nov 2021₪2.2b₪522.6m-₪155,277,310.0029.7x
Sun, 10 Oct 2021₪2.2b₪522.6m-₪147,005,403.0028x
Tue, 07 Sep 2021₪2.4b₪515.1m-₪150,674,423.5028.3x
Thu, 05 Aug 2021₪2.4b₪499.0m-₪147,462,423.5026.6x
Sun, 09 May 2021₪2.5b₪466.6m-₪189,880,366.5024.9x
Wed, 10 Feb 2021₪2.3b₪442.0m-₪259,485,185.2025.1x
Tue, 03 Nov 2020₪1.7b₪384.0m-₪288,523,540.9529.5x
Fri, 07 Aug 2020₪1.8b₪328.9m-₪330,614,786.0041.1x
Thu, 30 Apr 2020₪1.6b₪292.5m-₪291,139,946.8052.8x
Sun, 02 Feb 2020₪1.1b₪254.4m-₪156,223,485.0086.7x
Wed, 06 Nov 2019₪1.1b₪232.0m-₪39,702,894.0043.4x
Sat, 10 Aug 2019₪1.3b₪203.2m-₪37,809,169.8046.7x
Median PE Ratio

49.2x


Total Market Cap: ₪1.4bTotal Earnings: -₪37,809,169.80Total Revenue: ₪203.2mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Pharma Industry Median PE3Y Average 41.4x202020212022
Current Industry PE
  • Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry's 3-year average PS ratio 4.6x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 53% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Israeli Pharma compare with similar industries?

IL Market1.61%
Healthcare0.90%
Pharma3.30%
Pharma3.30%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
INCR InterCure₪20.752.4%
+₪21.7m
-9.1%PE63.1x
TKUN Tikun Olam-Cannbit Pharmaceuticals₪2.5810.4%
+₪10.9m
-52.7%PS3.1x
SEMG Seach Medical Group₪2.689.3%
+₪7.7m
-50.5%PE13.6x
CSURE Cannassure Therapeutics₪0.235.0%
+₪911.0k
-67.7%PS1.2x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News